Article Text

Download PDFPDF

Early and long-term outcome of infants born extremely preterm
Free
  1. Samantha Johnson1,
  2. Neil Marlow2
  1. 1Department of Health Sciences, University of Leicester, Leicester, UK
  2. 2Institute for Women's Health, University College London, London, UK
  1. Correspondence to Dr Samantha Johnson, Department of Health Sciences, University of Leicester, Centre for Medicine, University Road, Leicester LE1 7RH, UK; sjj19{at}le.ac.uk

Abstract

There is no question that birth at extremely low gestational ages presents a significant threat to an infant's survival, health and development. Growing evidence suggests that gestational age may be conceptualised as a continuum in which births before 28 weeks of gestation (extremely preterm: EP) represent the severe end of a spectrum of health and developmental adversity. Although comprising just 1%–2% of all births, EP deliveries pose the greatest challenge to neonatal medicine and to health, education and social services for the provision of ongoing support for survivors with additional needs. Studying the outcomes of these infants remains critical for evaluating and enhancing clinical care, planning long-term support and for advancing our understanding of the life-course consequences of immaturity at birth. Here we review literature relating to early and long-term neurodevelopmental, cognitive, behavioural and educational outcomes following EP birth focusing on key themes and considering implications for intervention.

  • preterm
  • outcomes
  • cognitive development
  • neurodevelopmental disability
  • special educational needs

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SJ and NM contributed equally to the drafting and revision of this manuscript.

  • Funding NM receives part funding from the Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme at University College London Hospital/UCL University College London.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Linked Articles

  • Atoms
    R Mark Beattie